Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
213.80    1.80 (0.85%)
Bid:
212.80
Ask:
213.20
Spread: 0.40 (0.188%)
Market Cap: £2.18b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Holding(s) in Company

20 Jun 2024 18:02

RNS Number : 2944T
Helios Towers PLC
20 June 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJVQC708

 

Issuer Name

HELIOS TOWERS PLC

 

UK or Non-UK Issuer

UK

 

2. Reason for Notification

An acquisition or disposal of voting rights

 

3. Details of person subject to the notification obligation

Name

Newlight Partners LP

 

City of registered office (if applicable)

New York

 

Country of registered office (if applicable)

United States

 

4. Details of the shareholder

 

Name

City of registered office

Country of registered office

 

 

Quantum Strategic Partners Ltd.

 

 

Cayman Islands

 

 

Cayman Islands

5. Date on which the threshold was crossed or reached

19-Jun-2024

6. Date on which Issuer notified

20-Jun-2024

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A +

8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

 

13.170000

 

0.000000

 

13.170000

 

138617444

Position of previous

notification (if applicable)

14.990000

0.000000

14.990000

 

 

8. Notified details of the resulting situation on the date on which the threshold

was crossed or reached

 

 

8A. Voting rights attached to shares

 

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

 

GB00BJVQC708

 

 

138617444

 

 

13.170000

 

 

 

Sub Total 8.A

 

 

138617444

 

 

13.170000%

 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 

 

Type of financial instrument

 

Expiration date

 

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

Sub

Total 8.B1

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

 

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

Sub

Total 8.B2

9. Information in relation to the person subject to the notification obligation

 

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

 

 

Ultimate controlling person

 

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Ravi Yadav

 

13.170000

 

13.170000%

 

 

Newlight GP LLC

 

 

13.170000

 

 

13.170000%

 

 

Newlight Partners LP

 

 

13.170000

 

 

13.170000%

 

 

David Wassong

 

 

13.170000

 

 

13.170000%

10. In case of proxy voting

Name of the proxy holder

 

 

The number and % of voting rights held

 

 

The date until which the voting rights will be held

 

 

11. Additional Information

 

 

 

12. Date of Completion

20-Jun-2024

 

13. Place Of Completion

New York, NY

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLPPUGUQUPCGMU
Date   Source Headline
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSUpdate on Omantel Tower Portfolio Acquisition
14th Nov 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding
7th Jun 20229:57 amRNSOmantel Tower Acquisition Update
5th May 202210:30 amRNSCapital Markets Day 2022
5th May 20227:00 amRNSQ1 2022 Results
29th Apr 202212:29 pmRNSDirector/PDMR Shareholding
28th Apr 20222:58 pmRNS2022 Annual General Meeting Results
20th Apr 202212:37 pmRNSNotice of Q1 2022 Results Date and CMD
28th Mar 20222:04 pmRNS2021 Annual Report & Accounts & 2022 Notice of AGM
25th Mar 20227:00 amRNSClosing of tower acquisition in Malawi
24th Mar 20229:11 amRNSDirector Declaration
21st Mar 20225:08 pmRNS2021 Annual Report and Accounts
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSFinal Results
10th Mar 20227:00 amRNSBoard Update - Director Changes
25th Feb 20227:00 amRNSAirtel Africa Tower Portfolio Transactions Update
11th Feb 20227:00 amRNSOmantel tower acquisition long-stop date extension
2nd Feb 20229:00 amRNSNotice of FY2021 Results Date & Conference Call
14th Dec 20212:12 pmRNSHolding(s) in Company
1st Dec 20215:12 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSCarbon Reduction Roadmap
3rd Nov 20217:00 amRNSClosing of tower acquisition in Madagascar
28th Oct 20217:00 amRNSQ3 2021 Results
22nd Oct 20218:25 amRNSDirector Declaration
11th Oct 20217:00 amRNSNotice of Q3 2021 Results Date & Conference Call
27th Sep 20213:33 pmRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNSUnaudited results for the 6 months ended 30 Jun 21
18th Aug 20215:00 pmRNSHelios Towers Announces CEO Transition
4th Aug 20217:00 amRNSNotice of H1 2021 Results Date & Conference Call
2nd Jul 20219:48 amRNSHolding(s) in Company
2nd Jul 20219:47 amRNSDirector/PDMR Shareholding
30th Jun 20216:11 pmRNSHolding(s) in Company
30th Jun 202111:12 amRNSTotal Voting Rights
18th Jun 20219:25 amRNSTotal Voting Rights
17th Jun 202112:46 pmRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSResults of Placing
15th Jun 20215:06 pmRNSRetail Offer via Primary Bid

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.